| Meta-analysis of phase II cooperative group trials in metastatic stage IV melanoma to determine progression-free and overall survival benchmarks for future phase II trials EL Korn, PY Liu, SJ Lee, JAW Chapman, D Niedzwiecki, VJ Suman, ... Journal of Clinical Oncology 26 (4), 527-534, 2008 | 820 | 2008 |
| Effects of mammography screening under different screening schedules: model estimates of potential benefits and harms JS Mandelblatt, KA Cronin, S Bailey, DA Berry, HJ De Koning, G Draisma, ... Annals of internal medicine 151 (10), 738-747, 2009 | 783 | 2009 |
| Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial FS Hodi, S Lee, DF McDermott, UN Rao, LH Butterfield, AA Tarhini, ... Jama 312 (17), 1744-1753, 2014 | 410 | 2014 |
| Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and … MB Atkins, J Hsu, S Lee, GI Cohen, LE Flaherty, JA Sosman, VK Sondak, ... Journal of Clinical Oncology 26 (35), 5748-5754, 2008 | 385 | 2008 |
| Human immunodeficiency virus type 1 V1-V2 envelope loop sequences expand and add glycosylation sites over the course of infection, and these modifications affect antibody … M Sagar, X Wu, S Lee, J Overbaugh Journal of virology 80 (19), 9586-9598, 2006 | 384 | 2006 |
| Soluble PD-L1 as a biomarker in malignant melanoma treated with checkpoint blockade J Zhou, KM Mahoney, A Giobbie-Hurder, F Zhao, S Lee, X Liao, S Rodig, ... Cancer immunology research 5 (6), 480-492, 2017 | 360 | 2017 |
| Association of screening and treatment with breast cancer mortality by molecular subtype in US women, 2000-2012 SK Plevritis, D Munoz, AW Kurian, NK Stout, O Alagoz, AM Near, SJ Lee, ... Jama 319 (2), 154-164, 2018 | 331 | 2018 |
| Collaborative modeling of the benefits and harms associated with different US breast cancer screening strategies JS Mandelblatt, NK Stout, CB Schechter, JJ Van Den Broek, DL Miglioretti, ... Annals of internal medicine 164 (4), 215-225, 2016 | 322 | 2016 |
| Combination Dabrafenib and Trametinib Versus Combination Nivolumab and Ipilimumab for Patients With Advanced BRAF-Mutant Melanoma: The DREAMseq … MB Atkins, SJ Lee, B Chmielowski, AA Tarhini, GI Cohen, TG Truong, ... Journal of Clinical Oncology 41 (2), 186-197, 2023 | 302 | 2023 |
| Mitoxantrone, etoposide, and cytarabine with or without valspodar in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome: a phase … PL Greenberg, SJ Lee, R Advani, MS Tallman, BI Sikic, L Letendre, ... Journal of clinical oncology 22 (6), 1078-1086, 2004 | 286 | 2004 |
| Phase III trial of carboplatin and paclitaxel with or without sorafenib in metastatic melanoma KT Flaherty, SJ Lee, F Zhao, LM Schuchter, L Flaherty, R Kefford, ... Journal of Clinical Oncology 31 (3), 373-379, 2013 | 269 | 2013 |
| Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic D Zhang, P Shankar, Z Xu, B Harnisch, G Chen, C Lange, SJ Lee, ... Blood, The Journal of the American Society of Hematology 101 (1), 226-235, 2003 | 242 | 2003 |
| Randomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus‐associated Kaposi sarcoma: evidence of symptom palliation from … M Cianfrocca, S Lee, J Von Roenn, A Tulpule, BJ Dezube, DM Aboulafia, ... Cancer 116 (16), 3969-3977, 2010 | 218 | 2010 |
| Spectrophotometric determination of oxidized and reduced pyridine nucleotides in erythrocytes using a single extraction procedure CR Zerez, SJ Lee, KR Tanaka Analytical biochemistry 164 (2), 367-373, 1987 | 192 | 1987 |
| Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality D Munoz, AM Near, NT Van Ravesteyn, SJ Lee, CB Schechter, O Alagoz, ... Journal of the National Cancer Institute 106 (11), dju289, 2014 | 190 | 2014 |
| Benefits, harms, and costs for breast cancer screening after US implementation of digital mammography NK Stout, SJ Lee, CB Schechter, K Kerlikowske, O Alagoz, D Berry, ... Journal of the National Cancer Institute 106 (6), dju092, 2014 | 168 | 2014 |
| Phase III study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk melanoma: North American Intergroup E1609 AA Tarhini, SJ Lee, FS Hodi, UNM Rao, GI Cohen, O Hamid, LF Hutchins, ... Journal of Clinical Oncology 38 (6), 567-575, 2020 | 166 | 2020 |
| Breast Cancer Working Group of the Cancer Intervention and Surveillance Modeling Network. Effects of mammography screening under different screening schedules: model estimates … JS Mandelblatt, KA Cronin, S Bailey, DA Berry, HJ de Koning, G Draisma, ... Ann Intern Med 151 (10), 738-747, 2009 | 162 | 2009 |
| Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk NT Van Ravesteyn, DL Miglioretti, NK Stout, SJ Lee, CB Schechter, ... Annals of internal medicine 156 (9), 609-617, 2012 | 155 | 2012 |
| Impact of the COVID-19 pandemic on breast cancer mortality in the US: estimates from collaborative simulation modeling O Alagoz, KP Lowry, AW Kurian, JS Mandelblatt, MA Ergun, H Huang, ... JNCI: Journal of the National Cancer Institute 113 (11), 1484-1494, 2021 | 152 | 2021 |
